Tenet Healthcare Corporation THC
Set alert
At close · Oct 30
After hours · Oct 30, 4:34 PM ET
- YTD
- +37.51%
- 1 year
- +30.98%
- Open
- 266.51
- Prev close
- 270.57
- Mkt cap
- 22.00B
- Vol
- 1.21M
- Avg vol
- 748.23K
- EPS
- 25.88
- P/E
- 10.56
- Div yield
- 0.00%
More statistics
- Low
- 265.58
- High
- 274.09
- Forward P/E
- 12.84
- Beta
- 1.20
- Short ratio
- 2.63
- Inst. own
- 101.92%
- Dividend
- 0.00
- Ex-div date
- Mar 12, 2000
- Earnings
- Feb 10, 2027
- 50-d avg
- 264.86
- 200-d avg
- 219.82
- 1y target
- 286.41
6M chart
Events in this range
- Jul 22, 2026Earnings: 6.12; estimate 4.26; surprise 43.66%
- Jul 28, 2026Rating: Truist Securities · Buy → Buy
- Aug 3, 2026Rating: Wells Fargo · Overweight → Overweight
- Sep 18, 2026Rating: Leerink Partners · Outperform → Outperform
- Sep 23, 2026Rating: BMO Capital · — → Market Perform
- Oct 16, 2026Rating: Guggenheim · Buy → Buy
- Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
- Oct 30, 2026Rating: Guggenheim · Buy → Buy
Signals (30)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 27, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 27, 2026 | 4 days ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 4, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | May 21, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
Key statistics
- Market cap
- 21.80B
- Enterprise value
- 36.40B
- Trailing P/E
- 10.46
- Forward P/E
- 12.84
- PEG ratio
- 1.88
- Price / sales
- 0.98
- Price / book
- 4.68
- EPS (TTM)
- 25.88
- Beta
- 1.20
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 13.09%
- Revenue (TTM)
- 22.15B
- Revenue growth
- 6.50%
- Free cash flow
- 2.00B
- Total cash
- 2.67B
- Total debt
- 13.24B
- Return on equity
- 41.70%
- Shares outstanding
- 80.52M
- Short % of float
- 2.68%
- 50-day average
- 264.86
- 200-day average
- 219.82
Analyst view
Consensus: buy
- Target (low)
- 260.00
- Target (mean)
- 286.41
- Target (high)
- 315.00
- Strong buy5
- Buy14
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 10, 2027
Expected Feb 10, 2027. Consensus EPS estimate 5.67.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2027 | Dec 30, 2026 | 5.45 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 4.68 | 6.64 | +1.96 | +41.88% |
| Jul 22, 2026 | Jun 30, 2026 | 4.26 | 6.12 | +1.86 | +43.66% |
| Apr 30, 2026 | Mar 31, 2026 | 4.17 | 4.82 | +0.65 | +15.59% |
| Feb 11, 2026 | Dec 31, 2025 | 4.07 | 4.70 | +0.63 | +15.48% |
| Oct 28, 2025 | Sep 30, 2025 | 3.34 | 3.70 | +0.36 | +10.78% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Guggenheim | main | Buy | Buy |
| Oct 16, 2026 | Guggenheim | main | Buy | Buy |
| Sep 23, 2026 | BMO Capital | init | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | main | Outperform | Outperform |
| Aug 3, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 28, 2026 | Truist Securities | main | Buy | Buy |
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- tenethealth.com
News
- Tenet Healthcare Q3 Earnings Call Highlights
- THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
- Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306
- THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
- Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript
- Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say
- Tenet Healthcare Q3 2026 Earnings Call Transcript
- Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates
- Tenet Healthcare Raises FY2026 Adj EPS Guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 Est; Narrows FY2026 Sales Guidance from $21.900B-$22.500B to $22.050B-$22.450B vs $22.351B Est
- Tenet Healthcare Raises FY2026 GAAP EPS Guidance from $34.57-$36.43 to $35.82-$37.08 vs $33.03 Est
Your note
Sign in to keep a note on THC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARBOUR PAOLA M | Chief Technology Officer | Sale | Jul 26, 2026 | 18,413 |
| BIERMAN JAMES L | Director | Sale | Jul 26, 2026 | 31,604 |
| FISHER RICHARD W. | Director | Conversion of Exercise of derivative security | May 21, 2026 | 9,632 |
| FITZGERALD MEGHAN | Director | Conversion of Exercise of derivative security | May 21, 2026 | 17,087 |
| HANEY CECIL D. | Director | Stock Gift | Aug 27, 2026 | 12,403 |
| MARK RICHARD J | Director | Sale | Sep 9, 2026 | 25,121 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.86% | 8,743,005 | 2.37B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 9.88% | 7,957,449 | 2.15B | Jun 29, 2026 |
| Boston Partners | 5.51% | 4,433,360 | 1.20B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.26% | 4,238,108 | 1.15B | Jun 29, 2026 |
| FMR, LLC | 4.96% | 3,994,545 | 1.08B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.84% | 3,894,189 | 1.05B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 2,868,116 | 776.69M | Sep 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Value Equity Trust | 3.53% | 2,840,356 | 769.17M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.40% | 2,734,962 | 740.63M | Jun 29, 2026 |
| T. Rowe Price Value Fund, Inc. | 2.60% | 2,092,106 | 566.54M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.45% | 1,975,296 | 534.91M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.84% | 1,483,123 | 401.63M | Aug 30, 2026 |